Bredin Investment’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$758K Hold
5,769
0.62% 42
2019
Q3
$645K Hold
5,769
0.56% 45
2019
Q2
$625K Hold
5,769
0.55% 45
2019
Q1
$749K Sell
5,769
-908
-14% -$110K 0.65% 39
2018
Q4
$773K Hold
6,677
0.73% 35
2018
Q3
$717K Hold
6,677
0.58% 40
2018
Q2
$570K Hold
6,677
0.44% 45
2018
Q1
$517K Hold
6,677
0.45% 45
2017
Q4
$565K Buy
+6,677
New +$568K 0.46% 43

Other funds holding LLY

Bredin Investment's LLY Position: Q4 2019 in Review

Bredin Investment held its Eli Lilly (LLY) position steady in Q4 2019 at 5,769 shares worth $758K. The position accounts for 0.62% of the portfolio, ranked #42.

Bredin Investment first reported a position in LLY in Q4 2017 and has held it in 9 quarters since. The position peaked at $773K in Q4 2018. 1,673 funds tracked by Wall St. Rank hold LLY as of Q4 2019.

  • Bredin Investment held 5,769 shares of Eli Lilly worth $758K as of Q4 2019.
  • Bredin Investment left its Eli Lilly share count unchanged in Q4 2019.
  • Eli Lilly made up 0.62% of Bredin Investment's portfolio in Q4 2019, its #42 holding.
  • Bredin Investment first reported a position in Eli Lilly in Q4 2017 and has held it in 9 quarters since.
  • Bredin Investment's Eli Lilly position peaked at $773K in Q4 2018.
  • 1,673 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2019.

Based on Bredin Investment's 13F filing for Q4 2019, filed 6 Feb 2020.